MedPath

Comparison of two local anaesthetics in spinal anaesthesia

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/04/041908
Lead Sponsor
Sree Balaji Medical College and Hospital
Brief Summary

0.75% ropivacaine has equal potency to 0.5% bupivacaine and Ropivacaine has been proven to be safer than Bupivacaine. However,  Bupivacaine is still commonly used in our country and readily-available 0.75% hyperbaric ropivacaine has not been studied so far in the Indian population. Hence, we are planning to conduct this study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

ASA 1&2 Undergoing infra umbilical surgery under subarachnoid block Consenting to participate in the study.

Exclusion Criteria

Patient refusal Allergy to local anaesthetics Local infection at the site of block Bleeding disorder Pre operative hypotension pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
onset and duration of sensory blockThe onset of sensory block at T10 will be monitored from positioning the patient after spinal anaesthesia at every 30 seconds and thereafter at every 3 minutes for the 1st 15 minutes and at every 30 minutes till it recedes to S2
Secondary Outcome Measures
NameTimeMethod
onset and duration of motor blockmotor block will be monitored from 0 minute at 30 seconds interval till grade 3 block according to modified Bromage scale is achieved and at 30 minutes interval till complete regression of motor block
hemodynamic disturbance and complications.vital parameters will be monitored from 0 minute at 3 minute interval till 1st 15 minutes, at 10 minutes interval during the surgery and at 30 minutes interval till complete recovery. fall in MAP or SBP more than 30% or heart rate below 50/min requiring pharmacological treatment will be noted and patient followed up for 24 hours to note other complications such as nausea vomiting, rashes, urinary retention if any

Trial Locations

Locations (1)

Sree Balaji Medical College and Hospital

🇮🇳

Kancheepuram, TAMIL NADU, India

Sree Balaji Medical College and Hospital
🇮🇳Kancheepuram, TAMIL NADU, India
Dr Gayathri Ramesh
Principal investigator
9004645828
docgayu@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.